Skip to main content

Table 5 Average % CV of triplicate test of 10 individuals over 3 days

From: Validation of a flow cytometry based chemokine internalization assay for use in evaluating the pharmacodynamic response to a receptor antagonist

 

CD14+MCP-1al+

CD4+MCP-1al+

 

%

MESF

%

N/A

Day 1

5.6

8.9

11.9

N/A

Day 2

2.2

8

13.9

N/A

Day 3

3

7.4

7.7

N/A

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us